Jing‐Yu Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jing‐Yu Zhao has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ai-Qun Chen
Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
1 shared publication - Dayang Chai
Department of Cardiology, The First People’s Hospital of Taicang, The Affiliated Taicang Hospital of Soochow University, Taicang, People’s Republic of China
1 shared publication - Feng Wang
Nanjing First Hospital, Nanjing Medical University
1 shared publication Jia‐Xian Song
The First People's Hospital of Zhangjiagang
1 shared publicationJuan Wang
Changshu No. 1 People's Hospital
1 shared publication- Jun-Jie Zhang
Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Impact of Intravascular Imaging‐Guided Drug‐Eluting Stent Implantation on Cardiac Death in Patients With Diabetes
Background: The clinical benefit of intravascular imaging (IVI)‐guided drug‐eluting stent implantation in patients with diabetes remains debated. The aim of this study was to compare 1‐year cardiac death between IVI‐guided and angiography‐guided drug‐eluting stent implantation in patients with diabetes. Methods: We analyzed 11 530 patients with diabetes and coronary artery disease who underwent drug‐eluting stent implantation from a prospective multicenter registry, stratified by IVI group (n=2425) and angiography group (n=9105). To minimize confounding, 1:1 propensity score matching was performed, resulting in 2409 matched pairs with balanced baseline clinical and angiographic characteristics. The primary end point was 1‐year cardiac death. Hazard ratios (HRs) with 95% CIs were estimated using Cox proportional hazards models, while Fine‐Gray subdistribution hazard models were used for outcomes with competing risks. Results: After propensity score matching, the IVI group had a greater number of implanted stents, longer total stent length, larger mean stent diameter, and larger post‐dilation balloon diameter (all P P P =0.011) and definite/probable stent thrombosis (0.9% versus 1.6%; HR 0.56; 95% CI 0.33–0.96; P =0.036) compared with angiography guidance. Conclusions: In patients with diabetes and coronary artery disease, IVI‐guided drug‐eluting stent implantation revealed a significantly lower risk of 1‐year cardiac death than angiography guidance.
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Open AccessImpact of Intravascular Imaging‐Guided Drug‐Eluting Stent Implantation on Cardiac Death in Patients With Diabetes
Background: The clinical benefit of intravascular imaging (IVI)‐guided drug‐eluting stent implantation in patients with diabetes remains debated. The aim of this study was to compare 1‐year cardiac death between IVI‐guided and angiography‐guided drug‐eluting stent implantation in patients with diabetes. Methods: We analyzed 11 530 patients with diabetes and coronary artery disease who underwent drug‐eluting stent implantation from a prospective multicenter registry, stratified by IVI group (n=2425) and angiography group (n=9105). To minimize confounding, 1:1 propensity score matching was performed, resulting in 2409 matched pairs with balanced baseline clinical and angiographic characteristics. The primary end point was 1‐year cardiac death. Hazard ratios (HRs) with 95% CIs were estimated using Cox proportional hazards models, while Fine‐Gray subdistribution hazard models were used for outcomes with competing risks. Results: After propensity score matching, the IVI group had a greater number of implanted stents, longer total stent length, larger mean stent diameter, and larger post‐dilation balloon diameter (all P P P =0.011) and definite/probable stent thrombosis (0.9% versus 1.6%; HR 0.56; 95% CI 0.33–0.96; P =0.036) compared with angiography guidance. Conclusions: In patients with diabetes and coronary artery disease, IVI‐guided drug‐eluting stent implantation revealed a significantly lower risk of 1‐year cardiac death than angiography guidance.